| 4-ABP | 4-aminobiphenyl |
| 8-oxoG | 8-oxi-7,8-dihydroguanine |
| AAH | Atypical adenomatous hyperplasia |
| ACE | Angiotensin-converting-enzyme |
| Ach | acetylcholine |
| ADC | Adenocarcinoma |
| ALK | Anaplastic lymphoma kinase |
| ARBs | Angiotensin receptor blockers |
| ARE | Antioxidant response element |
| ATBC | Alpha-Tocopherol Beta Carotene |
| B(a)P | Benzo[a]pyrene (B[a]P) |
| CARET | β-Carotene and Retinol efficacy Study |
| CDC | Center for Disease Control and Prevention |
| CIS | Squamous dysplasia and carcinoma |
| COPD | Chronic obstructive pulmonary disease |
| COX-2 | Cyclooxygenase-2 |
| DEC | Dysfunctional endothelial cells |
| EGFR | Epidermal growth factor receptor |
| EVALI | E-cigarette, or vaping, product use–associated lung injury |
| HNE | Trans-4-hydroxy-2-nonenal |
| IGF | Insulin-like growth factor |
| IEN | Intraepithelial neoplasia |
| Keap-1 | Kelch-like ECH-associated protein 1 |
| MDA | Malondialdehyde |
| nAChR | nicotinic acetylcholine receptor |
| NF-κB | Nuclear factor-κB |
| NNAL | Nnitrosamine alcohol |
| NNK | Nitrosamine ketone |
| NNN | N-nitrosonicotine |
| Nrf2 | Nuclear factor E2-related factor 2 |
| NSAIDs | Non-steroidal anti-inflammatory drugs |
| NSCLC | Non-small cell lung cancer |
| p38 MAPK | p38 mitogen-activated protein kinases |
| PGE-2 | COX2/prostaglandin E2 |
| PPARγ | Peroxisome proliferator-activated receptor gamma |
| ROS | Reactive oxygen species |
| SCLC | Small cell lung cancer |
| SCC | Squamous cell carcinomas |
| Se | Selenium |
| TKIs | TK inhibitors |
| TZD | Thiazolidinedione |